Beta-Carotene and Vitamin A: study protocols
29 study groups took Beta-Carotene together with Vitamin A. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Beta-Carotene
29 study groups in 21 studies say how much Beta-Carotene participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 25 mg to 50 mg, 66% of 29 study groups.
| Daily dose | Study groups |
|---|---|
| 500 mcg or less | 1 |
| 500 mcg to 1 mg | 2 |
| 1 mg to 2.5 mg | 2 |
| 2.5 mg to 5 mg | 3 |
| 5 mg to 10 mg | 0 |
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 19 |
Dose per serving from research: Vitamin A
19 study groups in 13 studies say how much Vitamin A participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 2,500 IU to 5,000 IU, 53% of 19 study groups.
| Daily dose | Study groups |
|---|---|
| 2,500 IU or less | 1 |
| 2,500 IU to 5,000 IU | 10 |
| 5,000 IU to 10,000 IU | 0 |
| 10,000 IU to 25,000 IU | 7 |
| 25,000 IU to 50,000 IU | 1 |
Commonly used together
14 of 29 study groups took Beta-Carotene and Vitamin A with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin E | 10 |
| Vitamin C | 7 |
| Selenium | 5 |
29 study groups
| Study | ||||
|---|---|---|---|---|
| Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group 1999 · vitamin A · pregnant HIV-infected women in their third trimester | 30 mg | 5,000 IU | — | 368 |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Vitamin A without multivitamin · HIV-positive pregnant Tanzanian women | 30 mg | 5,000 IU | — | — |
| Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial 2009 · CARET intervention arm · Men aged 45–69 or 50–69 who were current or former heavy smokers or asbestos-exposed workers; the report analyzes male participants only | 30 mg | 25,000 IU | — | — |
| Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among children born to HIV-infected women in Tanzania 2010 · Vitamin A plus β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks’ gestation in Dar es Salaam, Tanzania; treatment continued after delivery while breastfeeding was nearly universal | 30 mg | 5,000 IU | — | — |
| Plasma retinol and total carotenes and fracture risk after long-term supplementation with high doses of retinol 2014 · beta-carotene group · Adults aged 1990–1996 enrollment, 663 men and 335 women combined, in a cancer prevention program | 30 mg | 7.5 mg | 2847 days | — |
| Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer 1993 · retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis | 40 mg | 14,286 IU | 87 weeks | — |
| Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease 1996 · active-treatment group · Smokers, former smokers, and workers exposed to asbestos; age and sex not specified | 30 mg | 25,000 IU | 4 years | — |
| Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial 1996 · active intervention group · Men and women at high risk of developing lung cancer | 30 mg | 25,000 IU | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women | 30 mg | 5,000 IU | — | — |
| Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among children born to HIV-infected women in Tanzania 2010 · Multivitamins plus vitamin A and β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks’ gestation in Dar es Salaam, Tanzania; treatment continued after delivery while breastfeeding was nearly universal | 30 mg | 5,000 IU | — | — |
| Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer 1993 · riboflavin plus retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis | 40 mg | 14,286 IU | 87 weeks | — |
| Effects of vitamin A supplementation during pregnancy and early lactation on body weight of South African HIV-infected women 2001 · Pregnancy supplementation · HIV-seropositive pregnant women aged not stated, enrolled at 28–32 weeks gestation | 30 mg | 5,000 IU | — | — |
| The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers 1993 · retinol plus beta-carotene · Men and women aged 50–69 who were current smokers or had quit within the past 6 years and had a smoking history of at least 20 pack-years | 30 mg | — | 548 days | — |
| Bioefficacy of beta-carotene dissolved in oil studied in children in Indonesia 2001 · beta-carotene and retinyl palmitate capsules · Indonesian children aged 8–11 years | 160 mcg | 160 mcg | 10 weeks | 35 |
| Effect of supplementation with beta-carotene and vitamin A on lung nutrient levels 1998 · active arm · 21 men recruited to a lung nutrient biomarker study within CARET; age and underlying risk condition not specified | 30 mg | 25,000 IU | 26 weeks | 10 |
| Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women 2009 · vitamin A and β-carotene (VA+BC) · HIV-infected pregnant women enrolled at 12–27 weeks of gestation in Dar es Salaam, Tanzania; women breastfeeding postpartum | 30 mg | 5,000 IU | — | — |
| Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET) 2005 · Active intervention group (beta-carotene and/or retinol) · Adults in CARET Vanguard, including asbestos-exposed participants and smokers | 30 mg | 25,000 IU | 2557 days | 863 |
| Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial 2021 · Liposomal group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis | 4 mg | — | 90 days | 25 |
| Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial 2021 · Cyclodextrin group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis | 4 mg | — | 90 days | 25 |
| Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial 2021 · MCT group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis | 4 mg | — | 90 days | 25 |
| The effect of antenatal vitamin A and beta-carotene supplementation on gut integrity of infants of HIV-infected South African women 2001 · vitamin A group · HIV-infected pregnant South African women; age not stated | 30 mg | 1.5 mg | — | — |
| Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function 2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified | 25 mg | 500 mcg | 8 weeks | — |
| Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women 2009 · multivitamins including vitamin A and β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks of gestation in Dar es Salaam, Tanzania; women breastfeeding postpartum | 30 mg | 5,000 IU | — | — |
| The effect of long-term beta-carotene and vitamin A administration on serum concentrations of alpha-tocopherol 1994 · beta-carotene and vitamin A active agents · Participants enrolled in the Carotene and Retinol Efficacy Trial; age, sex, and health condition not specified | 30 mg | — | 6 years | — |
| Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) 1996 · intervention group · Patients with suspected acute myocardial infarction; age and sex not stated | 25 mg | 50,000 IU | 4 weeks | 63 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · Y2 · Healthy young adults aged 18–22 years | 1.5 mg | 3,000 IU | 60 days | 45 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · O2 · Healthy older adults aged 60–75 years | 1.5 mg | 3,000 IU | 60 days | 45 |
| [Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children] 2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area | 1 mg | 600 mcg | 8 weeks | 41 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · C2 · Healthy children aged 8–10 years | 1 mg | 2,000 IU | 60 days | 40 |